Gerresheimer
GXI.DE · XETRA
Bulios Fair Price
17.77 €
35.6% downside
Current Price
27.6 €
According to Bulios Fair Price, GXI.DE is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Gerresheimer AG (GXI) is a German multinational company specializing in the production and supply of specialty glass and plastics primarily for the pharmaceutical industry. With a broad range of products, such as injection vials, ampoules, and pharmacy containers, Gerresheimer AG is a key player in the pharmaceutical supply chain. The company is known for its innovative technology and high-quality standards, making it a preferred partner for pharmaceutical companies worldwide. Gerresheimer AG (GXI) could be an attractive investment opportunity for investors seeking stability and growth potential in the pharmaceutical supply sector.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Uwe Ferdinand Röhrhoff
Employees
13,528
Headquarters
Düsseldorf
Upcoming events
Earnings
Upcoming earnings report